PCRX · XBRL financial data

Viatris financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PCRX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	430	542	—	—	—	—
Revenue from contracts with customers	427	539	667	675	701	726
Cost of revenue	117	140	199	185	170	150
Research and development	59	56	85	76	82	117
Selling, general and administrative	194	199	255	269	294	369
Operating income (loss)	46	90	60	88	(73)	19
Interest income	5	1	5	11	20	23
Interest expense	26	32	40	20	17	17
Other income (expense)	3	(3)	(11)	(0)	(0)	(7)
Income tax expense (benefit)	(125)	14	(3)	20	36	10
Net income (loss)	146	42	16	42	(100)	7
Earnings per share, basic USD per share	3.41	0.95	0.35	0.91	(2.15)	0.16
Earnings per share, diluted USD per share	3.33	0.92	0.34	0.89	(2.15)	0.16
Weighted average shares, basic millions of shares	43	44	46	46	46	45
Weighted average shares, diluted millions of shares	44	46	47	52	46	45

Fiscal years (PCRX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	100	586	104	153	277	159
Short-term investments	422	71	185	125	208	80
Accounts receivable	53	96	98	106	113	124
Inventory	65	99	96	104	125	153
Prepaid and other current assets	12	15	15	22	22	33
Total current assets	652	866	498	510	745	548
Property and equipment, net	137	188	184	174	167	141
Right-of-use asset	74	76	71	61	49	42
Goodwill	100	145	163	163	0	20
Total assets	1,275	2,075	1,681	1,574	1,554	1,265
Accounts payable	10	11	15	16	19	15
Accrued liabilities	71	128	90	64	80	96
Current portion of long-term debt	—	—	—	—	202	0
Total current liabilities	253	521	148	97	310	121
Long-term debt	—	—	—	—	384	372
Lease liability, non-current	71	72	65	55	45	36
Total liabilities	655	1,345	906	704	775	572
Accumulated deficit	(254)	(212)	(149)	(107)	(206)	(199)
Total stockholders' equity	620	730	775	870	778	693
Total liabilities and equity	1,275	2,075	1,681	1,574	1,554	1,265
Common shares outstanding (cover page) millions of shares	44	45	46	47	46	40

Fiscal years (PCRX's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	146	42	16	42	(100)	7
Stock-based compensation	40	42	48	48	51	58
Depreciation and amortization	20	29	92	76	79	91
Net cash from operating activities	77	126	145	155	189	152
Purchases of property and equipment	38	46	30	15	11	15
Net cash from investing activities	(278)	(21)	(225)	78	(83)	99
Share repurchases	—	—	0	0	25	148
Net cash from financing activities	222	381	(402)	(183)	17	(370)
Net change in cash	22	486	(481)	49	123	(118)

No SIC code on file for this company, so there is no peer list.

No peers in the same industry and size range yet.

Not investment advice. Not affiliated with the U.S. SEC.